Schlüter T, Struy H, Schönfeld P
Institute for Biochemistry, Medical Faculty, Otto-von-Guericke-University, Magdeburg, Germany.
FEBS Lett. 2000 Sep 8;481(1):42-6. doi: 10.1016/s0014-5793(00)01923-2.
The suitability of the triaminopyridine derivative flupirtine, an analgesic drug with antioxidative property [Gassen, M., Pergande, G. and Youdim, M.B.H. (1998) Biochem. Pharmacol. 56, 1323-1329], for the preservation of mitochondrial integrity from oxidative stress-induced damage was studied. Rat liver mitochondria were exposed to strong oxidative stress as generated by Fe(2+) plus ascorbate. Peroxidation damage of membrane lipids was followed by the measurement of thiobarbituric acid reactive substances. Protein oxidation was estimated by electron spin resonance spectroscopy, after labeling of the 'peroxidized' mitochondria with 4-maleimido-2, 2,6,6-tetramethylpiperidine-1-oxyl. We found that (i) low concentrations of flupirtine (10 microM) protect lipids and also proteins (with lesser efficiency) from attacks of reactive oxygen species; (ii) flupirtine remarkably delayed the decline of complex mitochondrial functions, such as the respiratory control or the Ca(2+) retention capacity of mitochondria, under oxidative stress; and (iii) the ADP/ATP antiporter (ANT), a main component of the oxidative phosphorylation machinery as well as a core component of the permeability transition pore complex, seems to be a membrane protein particularly protected by flupirtine. In conclusion, the preservation of the Ca(2+) buffer capacity of mitochondria and of the ANT activity against oxidative stress supports an antiapoptotic application of flupirtine.
具有抗氧化特性的镇痛药三氨基吡啶衍生物氟吡汀[Gassen, M., Pergande, G.和Youdim, M.B.H. (1998) Biochem. Pharmacol. 56, 1323 - 1329]对保护线粒体完整性免受氧化应激诱导损伤的适用性进行了研究。大鼠肝线粒体暴露于由亚铁离子加抗坏血酸产生的强氧化应激中。通过测量硫代巴比妥酸反应性物质来跟踪膜脂的过氧化损伤。在用4 - 马来酰亚胺 - 2,2,6,6 - 四甲基哌啶 - 1 - 氧基标记“过氧化”线粒体后,通过电子自旋共振光谱法估计蛋白质氧化。我们发现:(i)低浓度的氟吡汀(10 microM)可保护脂质以及蛋白质(效率较低)免受活性氧的攻击;(ii)在氧化应激下,氟吡汀显著延迟了线粒体复杂功能的下降,如呼吸控制或线粒体的钙保留能力;(iii) ADP/ATP反向转运体(ANT)是氧化磷酸化机制的主要成分以及通透性转换孔复合体的核心成分,似乎是一种特别受氟吡汀保护的膜蛋白。总之,保护线粒体的钙缓冲能力以及ANT活性免受氧化应激支持了氟吡汀的抗凋亡应用。